- Home
- AVTR vs BXP Comparison
AVTR vs BXP Comparison
Compare AVTR & BXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTR
- BXP
- Stock Information
- Founded
- AVTR 1904
- BXP 1970
- Country
- AVTR United States
- BXP United States
- Employees
- AVTR N/A
- BXP N/A
- Industry
- AVTR Biotechnology: Laboratory Analytical Instruments
- BXP Real Estate Investment Trusts
- Sector
- AVTR Industrials
- BXP Real Estate
- Exchange
- AVTR Nasdaq
- BXP Nasdaq
- Market Cap
- AVTR 9.1B
- BXP 10.4B
- IPO Year
- AVTR 2019
- BXP 1997
- Fundamental
- Price
- AVTR $13.52
- BXP $71.47
- Analyst Decision
- AVTR Buy
- BXP Buy
- Analyst Count
- AVTR 13
- BXP 13
- Target Price
- AVTR $20.85
- BXP $77.85
- AVG Volume (30 Days)
- AVTR 10.9M
- BXP 1.7M
- Earning Date
- AVTR 07-25-2025
- BXP 07-29-2025
- Dividend Yield
- AVTR N/A
- BXP 5.45%
- EPS Growth
- AVTR 173.61
- BXP N/A
- EPS
- AVTR 1.04
- BXP N/A
- Revenue
- AVTR $6,685,200,000.00
- BXP $3,397,133,000.00
- Revenue This Year
- AVTR $0.52
- BXP $2.18
- Revenue Next Year
- AVTR $3.45
- BXP $2.72
- P/E Ratio
- AVTR $12.99
- BXP N/A
- Revenue Growth
- AVTR N/A
- BXP 3.47
- 52 Week Low
- AVTR $11.82
- BXP $54.22
- 52 Week High
- AVTR $28.00
- BXP $90.11
- Technical
- Relative Strength Index (RSI)
- AVTR 52.51
- BXP 56.84
- Support Level
- AVTR $12.99
- BXP $71.50
- Resistance Level
- AVTR $13.50
- BXP $73.61
- Average True Range (ATR)
- AVTR 0.43
- BXP 1.83
- MACD
- AVTR 0.06
- BXP -0.14
- Stochastic Oscillator
- AVTR 67.80
- BXP 64.42
About AVTR Avantor Inc.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.